NCI-H69/LX10

96042331, human lung, Not specified

• UNSPSCコード: 41106514

特性

• product name: NCI-H69/LX10, 96042331
• 由来生物: human lung
• 成長モード: Aggregates in suspension
• 核型: Not specified
• 形態: Not specified
• 製品: Not specified
• 受容体: Not specified
• テクニック: cell culture | mammalian: suitable
• 関連疾患: cancer
• 輸送温度: dry ice
• 保管温度: −196°C

詳細

細胞株の由来

Human small cell lung cancer, drug-resistant

細胞株の説明

The drug-resistant cell line NCI-H69/LX10 has been derived from the parent line NCI-H69 (ECACC No 91091802). It is recommended to culture the cells without drug upon resuscitation; add doxorubicine once growth is fully established.

アプリケーション

Drug-resistance studies

培地

RPMI 1640 + 2mM Glutamine + 1.0 μg/ml doxorubicine + 10% Foetal Bovine Serum (FBS).

継代と培養方法

Maintain cultures between 3-9 x 100,000 cells/ml; 5% CO₂, 37ºC; resuscitate in drug-free medium and add drug after growth has been established.

その他情報

Additional freight & handling charges may be applicable for Asia-Pacific shipments. Please check with your local Customer Service representative for more information.